Original Articles

Preferences of Pediatric Ophthalmologists and Vitreoretinal Surgeons of the Treatment of Scleral Perforations During Strabismus Surgery

Christopher K. Hwang, BA; Vidya P. Phoenix, MD; Amy K. Hutchinson, MD

  • Journal of Pediatric Ophthalmology and Strabismus
  • July/August 2011 - Volume 48 · Issue 4: 232-237
  • DOI: 10.3928/01913913-20100719-03
Rights and Permissions

Abstract

Purpose:

To evaluate the preferences of pediatric ophthalmologists and vitreoretinal surgeons with regard to the initial management of scleral perforation during strabismus surgery and to determine whether they perceived one mode of treatment conferred a significant advantage over another in terms of the complication rate.

Methods:

Six hundred sixty-five pediatric ophthalmologists and 494 vitreoretinal surgeons registered with their respective national organizations were invited by an e-mail to respond to an anonymous, web-based survey. The responses to the survey were compared between groups.

Results:

A total of 169 ophthalmologists participated, 133 of whom were pediatric ophthalmologists and 36 vitreoretinal surgeons. Significantly more pediatric ophthalmologists than vitreoretinal surgeons recommend initially managing scleral perforation by observation (P = .001). Among pediatric ophthalmologists, method of treatment was not perceived to affect outcome (P = .75). However, laser photocoagulation was perceived to result in the best outcome among vitreoretinal surgeons (P = .03).

Conclusion:

Significant differences exist among pediatric ophthalmologist and vitreoretinal surgeon management preferences and perceived treatment outcomes for scleral perforation.

AUTHORS

From the Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

Presented at the Joint Meeting of the American Academy of Ophthalmology, October 24–27, 2009, San Francisco, California.

Supported in part by an unrestricted grant to the Emory Eye Center from Research to Prevent Blindness, Inc., New York, New York.

The authors have no financial or proprietary interest in the materials presented herein.

Address correspondence to Amy K. Hutchinson, MD, Department of Ophthalmology, Emory University School of Medicine, 1365B Clifton Rd. NE, Atlanta, GA 30322. E-mail: ahutch2@emory.edu

Received: November 23, 2009
Accepted: May 12, 2010
Posted Online: July 22, 2010

doi: 10.3928/01913913-20100719-03

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.

[X]